Your browser doesn't support javascript.
loading
Case-control study of the association between select HLA genes and anti-erythropoietin antibody-positive pure red-cell aplasia.
Fijal, Bonnie; Ricci, Deborah; Vercammen, Els; Palmer, Peter A; Fotiou, Fotis; Fife, Daniel; Lindholm, Anders; Broderick, Erin; Francke, Stephan; Wu, Xiaodong; Colaianne, James; Cohen, Nadine.
Afiliação
  • Fijal B; Johnson & Johnson Pharmaceutical Research and Development, Raritan, NJ, USA.
Pharmacogenomics ; 9(2): 157-67, 2008 Feb.
Article em En | MEDLINE | ID: mdl-18370845
ABSTRACT

AIMS:

Antibody (Ab)-positive pure red-cell aplasia (PRCA) is a very rare but serious adverse event associated with recombinant human erythropoietin treatment (4.1 reports per 100,000 patient-years) in which patients produce antibodies to recombinant and endogenous erythropoietin, halting red blood cell production. In a previous case series, four Thai subjects with chronic kidney disease and Ab-positive PRCA were reported to have the HLA-DRB1*9 allele. To confirm a possible association of HLA-DRB1*9 and Ab-positive PRCA, we performed a pharmacogenomic analysis using subjects from an earlier case-control study of risk factors associated with Ab-positive PRCA, which had been performed using subjects from Europe or Canada. The primary goal of the analysis was to test the association between HLA-DRB1*9 and Ab-positive PRCA. A secondary goal was to perform an exploratory analysis in order to identify additional HLA alleles potentially associated with Ab-positive PRCA. PATIENTS &

METHODS:

Subjects were taken from a case-control study of Ab-positive PRCA in chronic kidney disease patients treated in Europe or Canada. Ab-positive PRCA cases (n=24) were matched to controls (n=81) by timing of treatment exposure and, when possible, by location.

RESULTS:

The allele frequency of HLA-DRB1*9 was 12.5% in cases vs 1.2% in controls (p=0.002). The frequency of the HLA-DRB1*9/other genotype was 25.0% in cases vs 2.5% in controls (p=0.004; OR 10.8 [95% CI 2.2-53.7]). Within the exploratory analysis, six additional HLA alleles (HLA-A*25, HLA-B*53, HLA-C*12, HLA-DQB1*3, HLA-DQB1*6 and HLA-DRB1*4) were also found to be associated with Ab-positive PRCA.

CONCLUSION:

This study confirmed that HLA-DRB1*9 occurs at a significantly higher frequency in Ab-positive PRCA cases than in controls; however, within this sample set, carrying the *9 allele was neither necessary nor sufficient to cause Ab-positive PRCA.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Autoanticorpos / Eritropoetina / Aplasia Pura de Série Vermelha / Antígenos HLA Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2008 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Autoanticorpos / Eritropoetina / Aplasia Pura de Série Vermelha / Antígenos HLA Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2008 Tipo de documento: Article